TAG:
private payer
Path Income Strategies Subject Of Symposium
By Robert Michel | From the Volume IV No. 13 – September 15, 1997 Issue
CEO SUMMARY: Public discussion of pathology income and compensation has been taboo for a good reason: the reality is one of contract cutbacks and declining reimbursement for pathology services. THE DARK REPORT is inviting a select group of astute pathologists to Scottsdale on November 8 t…
Private Insurers Sue SmithKline, Feds Pursue Labs In Six States
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
FRAUD AND ABUSE for laboratory billing is an issue which refuses to disappear. Private insurers filed a lawsuit against SmithKline Beecham last Thursday, seeking unspecified damages related to overcharging for laboratory testing during the years 1989-1995. At the same time, news eme…
“August 25, 1997 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
Meris Laboratories continues to be a turnaround challenge. The company announced on August 4 that CEO and President Denis Simon had resigned. Appointed by the board on March 25, Simon stayed less than 18 weeks in the position. Like several other California labs, the San Jose-based co…
Legislators May Repeal New York Lab Surcharge
By Robert Michel | From the Volume IV No. 10 – July 14, 1997 Issue
CEO SUMMARY: On January 1, New York State began to tax lab tests performed by free-standing laboratories with an 8.18% surcharge. The New York State Clinical Laboratory Association took its message directly to the public. Laboratories in New York State created enough consumer protest that…
Pap Smear Technologies Battle For Market Share
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three compan…
Laboratories Enter The Era Of Big Government
By R. Lewis Dark | From the Volume IV No. 4 – March 10, 1997 Issue
You will read in this issue of THE DARK REPORT how federal prosecutors have now taken all three of the national laboratories to the woodshed. SmithKline Beecham Clinical Laboratories was the latest to make the trip, paying $325 million to settle a wide variety of allegations and viol…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized